1830.HK
PERFECT MEDICALClosed1830.HK discounted cash flow valuation
1830.HK Fair Value
Reverse DCF: today's price implies -20.6% a year of FCF growth for years 1–5, against -5.0% in this model.
Model: -5.0% from 3-yr revenue CAGR (capped). Fades linearly to terminal growth by year 10.
Model: 8.84% (CAPM, see the build-up).
Long-run growth after year 10; keep it at or below nominal GDP.
Value Bridge
| PV of free cash flow, years 1–10 | HKD 1.63B |
|---|---|
| PV of terminal value (50% of EV) | HKD 1.62B |
| Enterprise value | HKD 3.25B |
| + Cash & investments | HKD 289.34M |
| − Total debt | −HKD 134.58M |
| Equity value | HKD 3.40B |
| ÷ Shares outstanding | 1.26B |
| Value per share | HKD 2.71 |
| Market cap | HKD 1.47B |
Discount Rate Build-up
| Risk-free rate (10-yr Treasury) | 5.29% |
|---|---|
| Beta (clamped 0.5–2.5) | 0.78 |
| Equity risk premium | 5.00% |
| Cost of equity (CAPM) | 9.19% |
| Pre-tax cost of debt | 5.91% |
| Tax rate | 15.6% |
| Debt / (equity + debt) | 8.4% |
| WACC | 8.84% |
Cost of debt is interest expense ÷ total debt, held between the risk-free rate and 12%.
Free Cash Flow: History and Projection
Sensitivity: Value per Share
| WACC ↓ / g → | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
|---|---|---|---|---|---|
| 6.84% | 3.30 | 3.52 | 3.80 | 4.15 | 4.60 |
| 7.84% | 2.83 | 2.98 | 3.15 | 3.37 | 3.63 |
| 8.84% | 2.48 | 2.59 | 2.71 | 2.85 | 3.02 |
| 9.84% | 2.22 | 2.30 | 2.38 | 2.48 | 2.60 |
| 10.84% | 2.01 | 2.07 | 2.13 | 2.21 | 2.29 |
Green is above today's price, red below (full colour at ±30%). The outlined centre cell is the current inputs.
Projected Cash Flows
| Year | Growth | Free cash flow | Discount factor | Present value |
|---|---|---|---|---|
| Base (FY2026) | — | HKD 309.22M | — | — |
| Year 1 | -5.0% | HKD 293.76M | 0.919 | HKD 269.90M |
| Year 2 | -5.0% | HKD 279.07M | 0.844 | HKD 235.58M |
| Year 3 | -5.0% | HKD 265.12M | 0.776 | HKD 205.62M |
| Year 4 | -5.0% | HKD 251.86M | 0.713 | HKD 179.48M |
| Year 5 | -5.0% | HKD 239.27M | 0.655 | HKD 156.65M |
| Year 6 | -3.5% | HKD 230.89M | 0.602 | HKD 138.89M |
| Year 7 | -2.0% | HKD 226.28M | 0.553 | HKD 125.06M |
| Year 8 | -0.5% | HKD 225.14M | 0.508 | HKD 114.33M |
| Year 9 | 1.0% | HKD 227.40M | 0.467 | HKD 106.09M |
| Year 10 | 2.5% | HKD 233.08M | 0.429 | HKD 99.91M |
Method
Two-stage free-cash-flow model, the same as the bot's lgf dcf: five years at the chosen growth rate, a straight-line fade to terminal growth by year ten, then a Gordon-growth terminal value. Everything is discounted at WACC.
Base cash flow is the trailing four quarters of operating cash flow minus capital expenditure (the latest fiscal year when quarters are missing). Default growth uses analyst long-term growth when Yahoo publishes it, else the average of next year's EPS and revenue growth, else revenue CAGR, held between −5% and 25%.
A DCF is only as good as its inputs. The terminal value is usually most of the answer, so read the sensitivity grid before the headline number. This is a model, not investment advice.